C30.0 Malignant neoplasm of nasal cavity

✓ Billable ICD-10-CM 2026
Open C30.0 in Web App →

The ICD-10-CM code for Malignant neoplasm of nasal cavity is C30.0 (FY2026). It is a billable, claim-ready diagnosis code.

Classification

Section
C30-C39: Malignant neoplasms of respiratory and intrathoracic organs (C30-C39)
Category C30
3 codes (2 billable)
FY2026 Status
Stable since FY2024

Also Known As

ICD-10-CM Alphabetic Index entries that lead to C30.0:

  • Esthesioneuroepithelioma
  • Esthesioneuroblastoma
  • Esthesioneurocytoma
  • Neuroblastoma › olfactory
  • Tumor › neurogenic olfactory
  • Neuroepithelioma › olfactory
  • Carcinoma (malignant) › Schneiderian › unspecified site
  • Schneiderian › specified site › unspecified site
Excludes1
Not coded here. These conditions should NOT be coded together with C30.0.
  • malignant neoplasm of nasal bone (C41.0)
  • malignant neoplasm of nose NOS (C76.0)
  • malignant neoplasm of olfactory bulb (C72.2-)
  • malignant neoplasm of posterior margin of nasal septum and choana (C11.3)
  • malignant melanoma of skin of nose (C43.31)
  • malignant neoplasm of turbinates (C41.0)
  • other and unspecified malignant neoplasm of skin of nose (C44.301, C44.311, C44.321, C44.391)

Inclusion Terms

  • Malignant neoplasm of cartilage of nose
  • Malignant neoplasm of nasal concha
  • Malignant neoplasm of internal nose
  • Malignant neoplasm of septum of nose
  • Malignant neoplasm of vestibule of nose

U.S. Hospital Utilization

  • An estimated 1,365 U.S. inpatient stays in 2023 included C30.0 among the documented diagnoses.
  • 690 stays listed it as the principal diagnosis.

Source: National Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, 2016–2023. National survey-weighted estimates.

Official Coding Guidelines

Tx of primary site (TOC entry)

a. Admission/Encounter for treatment of primary site ............................................................. 33

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.2.a
Tx of secondary site (TOC entry)

b. Admission/Encounter for treatment of secondary site .......................................................... 33

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.2.b

Source: CMS — ICD-10-CM Official Guidelines for Coding and Reporting, FY2026

References

Related Codes

Search all 70,000+ ICD-10-CM codes →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2025-10-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial